Cerner Collaboration to Increase Access to Cancer Clinical Trials

The company’s Learning Health Network t eams with Elligo Health Research and Freenome to Advance Early Cancer Detection
KANSAS CITY, Mo. Cerner Corporation (NASDAQ: CERN ), Elligo Health Research ® and Freenome are collaborating to enable a clinical trial through the Learning Health Network to help advance early cancer detection.

Read the source article at PR Newswire
2022-05-18 18:15:00